NFKB1 and cancer: Such deregulated activation enables NF-κB to transcriptionally reprogram cancer cells, promoting proliferation by upregulating cell cycle drivers, enhancing survival through antiapoptotic proteins, and facilitating metastasis via genes governing EMT and extracellular matrix remodeling, thus contributing to tumor progression (Fig. 4).